FR1601140A - - Google Patents

Info

Publication number
FR1601140A
FR1601140A FR1601140DA FR1601140A FR 1601140 A FR1601140 A FR 1601140A FR 1601140D A FR1601140D A FR 1601140DA FR 1601140 A FR1601140 A FR 1601140A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Inventor
G Anner
J Kalvoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1811967A external-priority patent/CH513837A/de
Priority claimed from CH1751368A external-priority patent/CH549002A/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR1601140A publication Critical patent/FR1601140A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR1601140D 1967-12-22 1968-12-19 Expired FR1601140A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1811967A CH513837A (de) 1967-12-22 1967-12-22 Verfahren zur Herstellung von 18-Methylensteroiden
CH1751368A CH549002A (de) 1968-11-25 1968-11-25 Verfahren zur herstellung von 18-methylensteroiden.

Publications (1)

Publication Number Publication Date
FR1601140A true FR1601140A (en:Method) 1970-08-10

Family

ID=25719621

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1601140D Expired FR1601140A (en:Method) 1967-12-22 1968-12-19
FR183293A Expired FR8264M (en:Method) 1967-12-22 1969-03-18

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR183293A Expired FR8264M (en:Method) 1967-12-22 1969-03-18

Country Status (15)

Country Link
US (2) US3584016A (en:Method)
JP (3) JPS5210870B1 (en:Method)
AT (5) AT313490B (en:Method)
BE (1) BE725788A (en:Method)
BR (1) BR6805022D0 (en:Method)
CA (3) CA940917A (en:Method)
DE (1) DE1815488A1 (en:Method)
DK (4) DK128239B (en:Method)
ES (1) ES361690A1 (en:Method)
FR (2) FR1601140A (en:Method)
GB (1) GB1255950A (en:Method)
HU (2) HU162956B (en:Method)
NL (1) NL6818447A (en:Method)
SE (6) SE374363B (en:Method)
SU (4) SU433676A3 (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52167736U (en:Method) * 1976-06-11 1977-12-19
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones

Also Published As

Publication number Publication date
GB1255950A (en) 1971-12-01
CA947275A (en) 1974-05-14
JPS5210870B1 (en:Method) 1977-03-26
NL6818447A (en:Method) 1969-06-24
HU162956B (en:Method) 1973-05-28
DK128241B (da) 1974-03-25
AT314745B (de) 1974-04-25
US3584016A (en) 1971-06-08
FR8264M (en:Method) 1970-10-19
ES361690A1 (es) 1970-12-16
SU450407A3 (ru) 1974-11-15
BR6805022D0 (pt) 1973-02-13
SE373846B (en:Method) 1975-02-17
HU162760B (en:Method) 1973-04-28
SU433676A3 (en:Method) 1974-06-25
DK128239B (da) 1974-03-25
CA940917A (en) 1974-01-29
SU432716A3 (ru) 1974-06-15
CA947276A (en) 1974-05-14
JPS4911696B1 (en:Method) 1974-03-19
AT301041B (de) 1972-08-25
AT324586B (de) 1975-09-10
US3842074A (en) 1974-10-15
AT325788B (de) 1975-11-10
SE356511B (en:Method) 1973-05-28
DE1815488A1 (de) 1969-07-24
AT313490B (de) 1974-02-25
SE374362B (en:Method) 1975-03-03
BE725788A (en:Method) 1969-06-20
SE373847B (en:Method) 1975-02-17
SU431670A3 (en:Method) 1974-06-05
SE374363B (en:Method) 1975-03-03
DK128735B (da) 1974-06-24
SE373844B (en:Method) 1975-02-17
DK126649B (da) 1973-08-06
JPS4831106B1 (en:Method) 1973-09-26

Similar Documents

Publication Publication Date Title
FR8264M (en:Method)
BE704231R (en:Method)
AU416737B2 (en:Method)
BE698681A (en:Method)
BE701538A (en:Method)
BE697014A (en:Method)
BE696839A (en:Method)
BE700171A (en:Method)
BE708900A (en:Method)
BE710858A (en:Method)
BE701182A (en:Method)
BE701842A (en:Method)
BE706550A (en:Method)
BE712955A (en:Method)
BE711030A (en:Method)
BE709880A (en:Method)
BE711124A (en:Method)
BE704307A (en:Method)
BE614676A (en:Method)
BE704512A (en:Method)
BE702543A (en:Method)
BE693472A (en:Method)
BE710234A (en:Method)
BE701472A (en:Method)
BE698392A (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse